Cholecystokinin-Positive Interneurons (CCK+) <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cck Positive Interneurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
</table>
Introduction Cck Positive Interneurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CCK+ interneurons are a major class of cortical GABAergic neurons characterized by cholecystokinin expression. These neurons represent approximately 25-30% of cortical interneurons and play crucial roles in regulating pyramidal neuron excitability, network oscillations, and cognitive function [1]. [@freund1990]
Overview
flowchart TD
CCK["CCK"] -->|"interacts with"| Nucleus_Tractus_Solitarius["Nucleus Tractus Solitarius"]
CCK["CCK"] -->|"biomarker for"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
style CCK fill:#4fc3f7,stroke:#333,color:#000
...
Cholecystokinin-Positive Interneurons (CCK+) <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cck Positive Interneurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0002277](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)</td>
</tr>
</table>
Introduction Cck Positive Interneurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CCK+ interneurons are a major class of cortical GABAergic neurons characterized by cholecystokinin expression. These neurons represent approximately 25-30% of cortical interneurons and play crucial roles in regulating pyramidal neuron excitability, network oscillations, and cognitive function [1]. [@freund1990]
Overview
Mermaid diagram (expand to render)
Cholecystokinin-positive (CCK+) interneurons are among the most abundant interneuron populations in the cerebral cortex and hippocampus. Unlike parvalbumin (PV+) basket cells, CCK+ basket cells preferentially target the soma and proximal dendrites of pyramidal neurons, providing powerful perisomatic inhibition. CCK+ interneurons are distinguished by their expression of the neuropeptide cholecystokinin and the cannabinoid receptor type 1 (CB1), which mediates activity-dependent modulation of inhibition [2]. [@herkenham1990]
<!-- taxonomy-enrichment --> [@cobb1999]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0002277)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)
[OBO Foundry (CL:0002277)](http://purl.obolibrary.org/obo/CL_0002277)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0002277)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002277)
[OBO Foundry (CL:0002277)](http://purl.obolibrary.org/obo/CL_0002277)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Structural Organization
Cellular Morphology CCK+ interneurons exhibit diverse morphological subtypes:
CCK+ basket cells : Characterized by dense axonal arborizations forming perisomatic baskets around pyramidal neuron somata. The axon initial segment is a primary target.Dendrite-targeting interneurons : Axons preferentially target distal dendrites of pyramidal neurons and interneuronsAxo-axonic cells : Some CCK+ neurons target axon initial segments (less common than PV+ axo-axonic cells)Bipolar/bitufted cells : Elongated dendritic trees spanning cortical layersSynaptic Connectivity CCK+ interneurons receive diverse inputs:
Local pyramidal neurons : Excitatory feedbackOther interneurons : Cross-inhibitionThalamocortical afferents : Sensory input integrationSubcortical modulators : Cholinergic, serotonergic inputsMolecular Markers
Primary Markers
CCK : Cholecystokinin peptide (primary defining marker)CNR1 (CB1) : Cannabinoid receptor type 1 - highest expression in brain [3]GAD1/GAD2 : GABA synthesis enzymesVGLUT3 : Vesicular glutamate transporter (co-release glutamate)Co-expressed Markers CCK+ neurons often co-express:
PV (PVALB) : Can be co-expressed in some subpopulationsCR (CALB2) : Calretinin in subsetVIP : Vasoactive intestinal peptide (partial overlap)nNOS : Neuronal nitric oxide synthase (subset)Reelin (RELN) : Some CCK+ basket cellsTranscription Factors
Lhx6 : Required for CCK+ interneuron developmentNpas1 : CCK+ interneuron specificationSatb1 : Chromatin regulator in CCK+ developmentElectrophysiological Properties
Firing Patterns CCK+ interneurons display characteristic firing properties:
Regular-spiking : Moderate firing ratesAdapting spike trains : Frequency adaptation during sustained depolarizationLow-threshold spiking : In some subtypesFast-spiking subset : Some CCK+ basket cells approach fast-spiking characteristicsMembrane Properties
Resting membrane potential : -65 to -70 mVInput resistance : 150-300 MΩMembrane time constant : 10-20 msAction potential duration : 0.5-1.0 msFunction
Perisomatic Inhibition CCK+ basket cells provide powerful inhibition at the soma [4]:
Timing control : Precisely timed inhibition regulates pyramidal neuron spike timingGain modulation : Control input-output functionsSynchronization : Coordinate pyramidal neuron firing ensemblesFeedback inhibition : Respond to elevated excitatory activityNetwork Oscillations CCK+ interneurons contribute to cortical oscillations:
Gamma oscillations (30-80 Hz) : CCK+ basket cells drive gamma through perisomatic inhibitionTheta oscillations (4-8 Hz) : Phase coupling with hippocampal interneuronsSharp wave-ripples : CCK+ cell activity during replay eventsModulation by Endocannabinoids The CB1 receptor provides unique modulation [5]:
Depolarization-induced suppression of inhibition (DSI) : Endocannabinoid release reduces CCK+ releaseActivity-dependent plasticity : CB1 enables flexible circuit modulation retrograde signaling : Postsynaptic activity triggers presynaptic modulationHomeostatic regulation : Maintains excitation-inhibition balanceVulnerability in Disease
Alzheimer's Disease CCK+ interneuron alterations in AD [6]:
CCK level changes : Decreased CCK in cortex and hippocampusCircuit dysfunction : Loss of perisomatic inhibitionGamma oscillation deficits : Impaired gamma rhythms correlate with memory impairmentCB1 receptor changes : Altered endocannabinoid signalingEarly vulnerability : CCK+ neurons may show early deficitsSchizophrenia
CCK receptor alterations : Changed CCK receptor density in prefrontal cortexGamma band deficits : Impaired gamma oscillations linked to working memory deficitsPerisomatic inhibition : Altered inhibition affecting pyramidal neuron functionGenetic associations : CCK gene polymorphisms linked to schizophrenia riskEpilepsy
CCK+ cell loss : Selective loss in temporal lobe epilepsyInhibition imbalance : Reduced perisomatic controlHyperexcitability : Failure to suppress seizure-like activityCB1 alterations : Changed cannabinoid modulation in epileptic tissueAutism Spectrum Disorders
CCK signaling : Altered CCK and receptor expressionCircuit-specific deficits : Imbalanced excitation/inhibitionSocial cognition : CCK's role in social behavior processingMolecular Mechanisms
CCK Signaling Cholecystokinin acts through CCK receptors [7]:
CCK1 receptors : Peripherally expressed, some CNS expressionCCK2 receptors : Primary CNS receptorG-protein coupling : Activate phospholipase C pathwayIntracellular effects : Increase intracellular Ca²⁺, activate PKCEndocannabinoid Signaling CB1 receptor mechanisms:
Endocannabinoids : Anandamide (AEA), 2-arachidonoylglycerol (2-AG)Presynaptic inhibition : Reduce GABA release probabilityActivity-dependent : Locally released during high activityMetabolic enzymes : FAAH, MAGL for degradationTherapeutic Implications
Targeting CCK+ Circuits Potential therapeutic approaches:
CCK agonists : Enhance CCK signaling for cognitive enhancementCB1 modulators : Strategic modulation of endocannabinoid signalingGamma oscillation enhancers : Restore gamma rhythmsCircuit-specific interventions : Targeted manipulation of CCK+ networksClinical Significance
Biomarker potential : CCK levels as disease progression markersTreatment targets : CCK receptor drugs in developmentCognitive enhancement : CCK's role in memory consolidationParvalbumin-Positive Interneurons
Somatostatin-Positive Interneurons
Vasoactive Intestinal Peptide (VIP+) Interneurons
Cortical Pyramidal Neurons
[GABAergic Neurons](/cell-types/gabaergic-neurons)](/entities/neurons)
[Alzheimer's Disease](/diseases/alzheimers-disease)
Gamma Oscillations
Background The study of Cck Positive Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[Nature Reviews Neuroscience: CCK interneurons](https://www.nature.com/articles/nrn.2017.51)interneurons)
[NCBI: CCK in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/25890251/)neurodegeneration)
[Allen Brain Atlas: CCK expression](https://human.brain-map.org/)
Show full description